Aytu Biopharma Inc
NASDAQ:AYTU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aytu Biopharma Inc
NASDAQ:AYTU
|
US |
|
C
|
Charlie's Holdings Inc
OTC:CHUC
|
US |
|
SBI Holdings Inc
F:ZOF
|
JP |
|
A
|
American Coastal Insurance Corp
NASDAQ:ACIC
|
US |
|
T
|
Tate & Lyle PLC
XBER:TLY
|
UK |
Wall St Price Targets
AYTU Price Targets Summary
Aytu Biopharma Inc
According to Wall Street analysts, the average 1-year price target for AYTU is 9.69 USD with a low forecast of 7.07 USD and a high forecast of 15.23 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AYTU's stock price target?
Price Target
9.69
USD
According to Wall Street analysts, the average 1-year price target for AYTU is 9.69 USD with a low forecast of 7.07 USD and a high forecast of 15.23 USD.
What is the Revenue forecast for Aytu Biopharma Inc?
Projected CAGR
13%
Over the last 9 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 3 years is 13%.
What is the Gross Profit forecast for Aytu Biopharma Inc?
Projected CAGR
13%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 45%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Aytu Biopharma Inc?
Projected CAGR
78%
The compound annual growth rate for Operating Income over the next 3 years is 78%.
